Once the beta-interferon administration was ceased and upon the initiation of methylprednisolone, the symptoms remitted.<h4>Conclusions</h4>In this case study, we portrayed the particular association between the remission phase of multiple sclerosis and the violent onset of interferon-induced thrombotic thrombocytopenic purpura. This evidence concerns the gene IFNB1 and multiple sclerosis.